Cargando…

NON RESPONSIVENESS TO ECT -- AN ADDITIONAL PRE-REQUISITE FOR CLOZAPINE THERAPY

Detalles Bibliográficos
Autor principal:	Pandey, S.K.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 1996
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970887/ https://www.ncbi.nlm.nih.gov/pubmed/21709853

Ejemplares similares

The Problem Schizophrenic : Clozapine or ECT?
por: Andrade, C.
Publicado: (1996)

Combination of ECT and clozapine in drug-resistant schizophrenia
por: Kurian, S., et al.
Publicado: (2005)

Adherence to review protocol and rigorous methodology are the pre-requisites of a well-conducted systematic review
por: Taguchi, Sagiri, et al.
Publicado: (2019)

Dietary counseling: A requisite in geriatric prosthodontics
por: Shigli, Kamal, et al.
Publicado: (2020)

AGRANULOCYTOSIS DURING CLOZAPINE THERAPY
por: Jagadheesan, K., et al.
Publicado: (2000)

CLINICAL PREDICTORS OF RESPONSE TO ECT IN SEVERE DEPRESSION
por: Agrawal, Arun Lata
Publicado: (2001)

CARDIOVASCULAR EFFECTS OF ECT
por: Chaudhury, Suprakash, et al.
Publicado: (2001)

Role of ECT in Schizophrenia
por: Chopra, H.D.
Publicado: (1986)

Althesin in modified ECT
por: Andrade, Chittaranjan, et al.
Publicado: (1990)

UNILATERAL ECT AND DOSING
por: Andrade, Chittaranjan
Publicado: (2000)

PREDICTION OF ANTIDEPRESSANT EFFICACY FROM RESPONSE TO THE FIRST ECT
por: Andrade, Chittaranjan
Publicado: (1998)

ECT IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Jagadisha,, et al.
Publicado: (2003)

National workshop on ECT practice
por: Jagadisha,, et al.
Publicado: (2005)

MODIFIED VERSUS UNMODIFIED ECT
por: Shukla, G.D.
Publicado: (2000)

Fidelity of Ect Devices: An alert to Clinicians
por: Andrade, Chittaranjan
Publicado: (2004)

ECT and Clozapine combination producing delirium : A Case Report
por: Kumar, Satindra, et al.
Publicado: (2003)

IS A GRANDMAL SEIZURE NECESSARY AND SUFFICIENT FOR THE EFFICACY OF ECT?
por: Gangadhar, B.N., et al.
Publicado: (2000)

IS MONITORING OF PLATELETS NECESSARY DURING CLOZAPINE THERAPY ?
por: Tharyan, Prathap
Publicado: (1999)

Unexpected increase of the compliance rate of transfusion requisition form after the COVID-19 outbreak
por: Yang, L., et al.
Publicado: (2021)

MODIFIED VERSUS UNMODIFIED ECT : IS THERE A PARADIGM SHIFT?
por: Duggal, Harpreet S., et al.
Publicado: (2001)

Anesthesiological training and certification for psychiatrists practising unmodified ECT
por: Andrade, Chittaranjan
Publicado: (2013)

Occupational team safety in ECT practice and COVID-19
por: Mungmunpuntipantip, Rujitika, et al.
Publicado: (2021)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Clozapine Use in Adolescents
por: Praharaj, Samir Kumar
Publicado: (2017)

Clozapine: A friend estranged?
por: Agarwal, Mahavir, et al.
Publicado: (2011)

Clozapine-induced Delayed Ejaculation
por: Das, Soumitra, et al.
Publicado: (2017)

Clozapine-induced Tardive Dyskinesia
por: Das, Soumitra, et al.
Publicado: (2017)

The basal position of nuclei is one pre-requisite for asymmetric cell divisions in the early mouse embryo
por: Ajduk, Anna, et al.
Publicado: (2014)

Lorazepam-induced prolonged apnea after ECT-induced prolonged seizure
por: Dhavale, Dattatreya, et al.
Publicado: (2011)

Occupational team safety in ECT practice during the COVID-19 pandemic
por: Araujo, Renato Ferreira, et al.
Publicado: (2020)

Meningomyelocele on Exposure to Clozapine During Perinatal Period
por: Narayanaswamy, Prakruthi, et al.
Publicado: (2019)

THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
por: Pfizer, N., et al.
Publicado: (2002)

CLOZAPINE FOR PSYCHOTIC AND BEHAVIOURAL PROBLEMS IN DEMENTIA
por: Srinivasan, T.N.
Publicado: (1999)

Clozapine Induced Supra Ventricular Tachycardia
por: Kirpekar, C. Vivek, et al.
Publicado: (2015)

Late-onset neutropenia due to clozapine
por: Tatar, Zeynep Baran, et al.
Publicado: (2015)

Clozapine Toxicity in the Setting of COVID-19
por: Dotson, Samuel, et al.
Publicado: (2020)

RABBIT SYNDROME - AN UNCOMMON SIDE EFFECT OF NEUROLEPTIC THERAPY
por: Pandey, S.K.
Publicado: (1998)

Structure pre-requisites for isoflavones as effective antibacterial agents
por: Mukne, Alka P., et al.
Publicado: (2011)

Drugs That Are Requisite
por: Boyd, James
Publicado: (1940)

Cannot write session to /tmp/vufind_sessions/sess_rh1bf6qds0o46j4dkbr6236o5e